Inmaculada de Melo-Martin

Inmaculada de Melo-Martin serves as Professor of Population Health Sciences at Weill Cornell Medical College, with concurrent appointments as Professor of Medical Ethics in Medicine and Professor of Medical Ethics in Reproductive Medicine since 2014. Her academic career bridges bioethics, medical ethics, and reproductive ethics within Cornell University's prestigious medical institution, where she contributes to both clinical practice guidance and theoretical ethical frameworks.

Her educational journey began with a Laurea from the University of Oviedo (Spain) in 1991, followed by an M.S. from the University of Texas in 2004, and culminated in a Ph.D. from the University of South Florida in 1997. This multidisciplinary foundation supports her research at the intersection of ethics, medicine, and policy.

De Melo-Martin's research focuses on critical ethical challenges in modern medicine, particularly examining genetic technologies, reproductive ethics, and research integrity. Her work critically analyzes emerging technologies like CRISPR while addressing practical clinical dilemmas in patient care, informed consent processes, and healthcare disparities. She maintains particular expertise in ethical considerations surrounding refugee healthcare, embryo research, and conflicts of interest in scientific research.

Analysis of her recent publications reveals a consistent focus on the ethical dimensions of rapidly advancing medical technologies, with increasing attention to justice considerations in genetic applications and the practical implementation of ethical principles in clinical settings. Her scholarship demonstrates both theoretical depth in philosophical ethics and practical relevance to contemporary medical practice.

As an active researcher, she serves as Co-Investigator for the Clinical and Translational Science Center grant (2025-2030) funded by the National Center for Advancing Translational Sciences, demonstrating sustained research productivity and funding success.

Professionally, she contributes as an Advisory/Scientific Board Member for the Crohn's & Colitis Foundation of America and provides Professional Services for the Centro Nacional de Investigaciones Oncologicas, reflecting her standing as an ethics expert sought by major medical organizations.